多队列机器学习识别了帕金森病中认知障碍的预测因素
Rebecca Ting Jiin Loo1, Lukas Pavelka2, Graziella Mangone3
1Biomedical Data Science Group, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
NPJ digital medicine
|July 27, 2025
概括
机器学习模型可以预测帕金森病 (PD) 的认知衰退. 使用多队列数据,研究人员确定了关键预测因素,如年龄和视觉空间能力,用于早期检测和个性化管理.
科学领域:
- 神经学 神经学
- 人工智能的人工智能
- 生物统计学 生物统计学
背景情况:
- 认知障碍影响高达50%的帕金森病 (PD) 患者.
- 早期检测和风险评估对于管理PD相关认知衰退至关重要.
研究的目的:
- 开发和验证用于预测轻度认知障碍 (PD-MCI) 和主观认知衰退 (SCD) 的机器学习模型.
- 利用可解释的人工智能 (XAI) 提高模型解释性和确定关键预测因素.
主要方法:
- 利用了来自三个独立的帕金森病队列 (LuxPARK,PPMI,ICEBERG) 的临床数据.
- 训练有素的机器学习模型用于分类和时间到事件分析,以预测PD-MCI和SCD.
- 采用XAI技术来理解模型预测和识别重要的预测因素.
主要成果:
- 与单一队列模型相比,多队列模型显示出更高的性能稳定性.
- 诊断时的年龄和视觉空间能力成为认知衰退的主要预测因素.
- 观察到显著的性别差异,男性更容易报告SCD,强调需要针对性别的具体考虑.
结论:
- 多队列机器学习为早期识别帕金森病的认知障碍提供了强大的方法.
- 这些发现支持了个性化管理策略的潜力,这些策略是根据个人风险概况和性别特异因素量身定制的.
更多相关视频
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.4K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
相关概念视频
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Cognitive Development During Adulthood
282
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
282
